[Daratumumab, bortezomib, lenalidomide and dexamethasone in patients treated for multiple myeloma eligible for autologous stem cell transplantation].

{"title":"[Daratumumab, bortezomib, lenalidomide and dexamethasone in patients treated for multiple myeloma eligible for autologous stem cell transplantation].","authors":"Minh Quang Pham, Carolyne Croizier","doi":"10.1016/j.bulcan.2025.02.013","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":93917,"journal":{"name":"Bulletin du cancer","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin du cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.bulcan.2025.02.013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}